Outcomes following repeat exenteration for locally advanced pelvic malignancy.

Joshua BlakeCherry E KohDaniel SteffensMarie Shella De RoblesKilian BrownPeter LeeKirk AustinMichael J Solomon

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2020)

This study demonstrates that repeat exenteration for recurrent pelvic malignancy is feasible but is associated with increased complication rates and length of admission and reduced likelihood of attaining R0 margin. Moreover, these data indicate that repeat exenteration does not afford a survival advantage compared with patients having a single exenteration. These data suggest that repeat exenteration for recurrent pelvic malignancy may be of questionable therapeutic value.

Keyphrases

rectal cancer
end stage renal disease
electronic health record
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
big data
prognostic factors
machine learning
deep learning